Sigyn Therapeutics Inc (SIGY)
5.25
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Sigyn Therapeutics Enterprise Value: 8.874M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
June 14, 2024 | 8.874M |
June 13, 2024 | 8.874M |
June 12, 2024 | 8.874M |
June 11, 2024 | 8.874M |
June 10, 2024 | 8.874M |
June 07, 2024 | 8.874M |
June 06, 2024 | 8.874M |
June 05, 2024 | 8.874M |
June 04, 2024 | 8.874M |
June 03, 2024 | 8.874M |
May 31, 2024 | 8.874M |
May 30, 2024 | 8.874M |
May 29, 2024 | 8.874M |
May 28, 2024 | 8.874M |
May 24, 2024 | 8.874M |
May 23, 2024 | 8.874M |
May 22, 2024 | 8.874M |
May 21, 2024 | 8.874M |
May 20, 2024 | 8.874M |
May 17, 2024 | 8.874M |
May 16, 2024 | 8.874M |
May 15, 2024 | 8.874M |
May 14, 2024 | 8.568M |
May 13, 2024 | 8.568M |
May 10, 2024 | 8.568M |
Date | Value |
---|---|
May 09, 2024 | 8.568M |
May 08, 2024 | 8.568M |
May 07, 2024 | 8.568M |
May 06, 2024 | 8.874M |
May 03, 2024 | 8.874M |
May 02, 2024 | 8.874M |
May 01, 2024 | 9.180M |
April 30, 2024 | 9.793M |
April 29, 2024 | 10.21M |
April 26, 2024 | 10.21M |
April 25, 2024 | 9.487M |
April 24, 2024 | 9.487M |
April 23, 2024 | 9.487M |
April 22, 2024 | 9.487M |
April 19, 2024 | 9.487M |
April 18, 2024 | 9.180M |
April 17, 2024 | 9.915M |
April 16, 2024 | 9.915M |
April 15, 2024 | 9.915M |
April 12, 2024 | 9.793M |
April 11, 2024 | 9.180M |
April 10, 2024 | 9.180M |
April 09, 2024 | 9.180M |
April 08, 2024 | 9.180M |
April 05, 2024 | 9.180M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.964M
Minimum
Aug 14 2020
111.31M
Maximum
Feb 19 2021
16.53M
Average
9.243M
Median
Mar 15 2023
Enterprise Value Benchmarks
CEL-SCI Corp | 65.10M |
AIM ImmunoTech Inc | 15.35M |
IGC Pharma Inc | 25.36M |
NovaBay Pharmaceuticals Inc | 3.382M |
Protalix BioTherapeutics Inc | 55.51M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.7581M |
Total Expenses (Quarterly) | 0.63M |
EPS Diluted (Quarterly) | -0.62 |
Earnings Yield | -60.76% |
Normalized Earnings Yield | -4515.18 |